← FDA Drug Approvals (Drugs@FDA)

MOTPOLY XR

NDA · New Drug Application · Sponsor: AUCTA · Approved 2023-05-04

Drug application

FDA Application #

NDA216185

Application type

New Drug Application

Brand name

MOTPOLY XR

Generic name

LACOSAMIDE

Active ingredients

LACOSAMIDE

Dosage form

CAPSULE, EXTENDED RELEASE

Route

ORAL

Marketing status

Prescription

Sponsor

AUCTA

Manufacturer

Aucta Pharmaceuticals, Inc.

First approval

2023-05-04

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown